TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

CONSOLIDATED PHARM

Infectious DiseaseGastroenterologyDermatology
Pharma

CONSOLIDATED PHARM is a pharmaceutical company focused on Infectious Disease, Gastroenterology, Dermatology.

-
Since
3
Drugs
-
Trials
26
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

PENICILLIN G PROCAINE 2025-08-26
Labeling
PENICILLIN G PROCAINE 2025-08-26
Labeling
PENICILLIN G PROCAINE 2025-08-26
Labeling
PENICILLIN G PROCAINE 2024-06-07
Labeling
PENICILLIN G PROCAINE 2024-06-07
Labeling
PENICILLIN G PROCAINE 2024-06-07
Labeling
PENICILLIN G PROCAINE 2024-06-07
Labeling
AMPICILLIN SODIUM 2024-05-01
Labeling
AMPICILLIN SODIUM 2024-05-01
Labeling
AMPICILLIN SODIUM 2024-05-01
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%
2 drugs
Gastroenterology 25%
1 drugs
Dermatology 25%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

Pfizer big-pharma
Infectious Disease, Dermatology, Gastroenterology
APOTHECON specialty
Infectious Disease, Dermatology, Gastroenterology
Baxter specialty
Infectious Disease, Dermatology
CASPER PHARMA LLC big-pharma
Infectious Disease, Gastroenterology, Dermatology
B BRAUN specialty
Infectious Disease, Dermatology